Found: 6
Select item for more details and to access through your institution.
A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 3, p. 405, doi. 10.3390/biom12030405
- By:
- Publication type:
- Article
Preclinical Evaluation of a New Series of Albumin-Binding 177 Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics.
- Published in:
- Molecules, 2023, v. 28, n. 16, p. 6158, doi. 10.3390/molecules28166158
- By:
- Publication type:
- Article
Performance of PSMA-targeted radiotheranostics in an experimental model of renal cell carcinoma.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1432286
- By:
- Publication type:
- Article
Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 2044, doi. 10.1093/neuonc/noad097
- By:
- Publication type:
- Article
Correction to: Hetero-bivalent agents targeting FAP and PSMA.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Hetero-bivalent agents targeting FAP and PSMA.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4369, doi. 10.1007/s00259-022-05933-3
- By:
- Publication type:
- Article